InfoAnda - Health Investors' New Calculus: Save Money To Make Money

Pakistanis angry over detentions in Times Sq. case
Monday, May 24, 2010
ISLAMABAD – Relatives of three men detained by Pakistan for alleged links to the suspect in the attempted Times Square bombing say the men are innocent.
They

Taiwan denies boycotting Australian film festival
Thursday, August 6, 2009

AFP - Thursday, August 6TAIPEI (AFP) - - Taiwan's Beijing-friendly government on Wednesday denied boycotting an Australian film festival amid a row over the e

Merkel's support dips, regional ally resigns International
Thursday, September 3, 2009

By Sarah Marsh and Noah Barkin

BERLIN (Reuters) - Chancellor Angela Merkel suffered a double blow on Thursday as a senior party ally in east German

Minister seeks closure of anti-Berlusconi websites
Wednesday, December 16, 2009
ROME (AFP) - – The Italian government moved Tuesday to close down Internet sites encouraging further violence against Prime Minister Silvio Berlusconi, who

Asian markets mixed after Wall Street rally
Wednesday, March 18, 2009

By ELAINE KURTENBACH,AP Business Writer AP - Wednesday, March 18SHANGHAI - Asia's stock market rally seemed to be running out of steam Wednesday, despite an

Activity detected at North Korea nuclear test site: report | | 21 October 2010
Britain ends military operations in Iraq | 30 April 2009
Bond film opens with guns blazing in Britain | Entertainment | | 1 November 2008

80 Afghan schoolgirls fall ill; poison feared | 26 April 2010

Advertisement Health Investors' New Calculus: Save Money To Make Money Source: (KaiserHealth) Reporter: KaiserHealth Staff Location: Washington, DC, United States Published: November 6, 2011 07:32 am EST Topics: Health, Economy, Business And Finance, Financial And Business Service, Healthcare Provider Over the last two decades, venture capitalists helped make possible striking advances in health care, including robotic surgery, cancer vaccines and genomics. But such innovations also fuel higher health care spending, and now private investors see new opportunities in betting on companies that could curb those costs. America's health care spending is "twice what it was ten years ago, and it's forecasted to grow in an unaffordable way for the country," said John Doerr, the Kleiner Perkins Caufield & Byers partner who backed Google, Twitter and other technology giants. Doerr’s answer to the health care problem is Essence Group Holding Corp., a St. Louis health plan he bought in 2007 and converted into a laboratory to develop software and services to help doctors and insurers tackle costs. Doerr isn't alone in spotting an opportunity in health care's high costs. Venture capitalists are increasingly interested in nuts-and-bolts businesses like data mining and grassroots care management. Meanwhile, the appeal of companies that seek high-ticket, high-risk medical breakthroughs is on the wane. The share of venture dollars flowing to seed and early stage investments in biotechnology and medical devices has plummeted since 2007, when investors pumped $3.6 billion into 332 deals in which a price was disclosed, according to data compiled for Kaiser Health News by FactSet Research Systems. As of late October, investors had spent $1.1 billion on only 89 such deals this year. Overall venture investing declined by nearly one-third as the economic recession set in, but is on track this year to return to nearly pre-recession levels. "There’s a realization that part of the health care cost problem is adding on the bells and whistles of [medical] technology," said Ian Morrison, a health care consultant based in Menlo Park, Calif. "The smart money is recognizing that's not the winning formula for the future." Some of that money is increasingly going to information technology, business services and other health-focused companies. For instance, software companies that cater to the health care industry saw $407 million in investments in the first three quarters of this year, compared with $311 million for the full year in 2007 before the recession, according to PricewaterhouseCoopers researchers, who compile the industry-backed quarterly MoneyTree Report. Though the increase so far remains modest –not yet approaching the e-health boom in 2000--investors say interest in the sector is heating up. Venture capitalists are still looking for strong companies in all sectors – drugs, devices, and services – but, cost concerns and other factors have led to changes in demand. Investors are wagering customers will pay attention to the promise of lower costs. "If you come in with [a device] that's 10 percent better and twice as expensive, it's hard to get anyone to care," said Bryan Roberts, a Palo Alto, Calif.-based venture capitalist at Venrock who invests both in health services and device and drug makers. Doerr's firm, Kleiner Perkins, and Camden Partners, put $61 million into Essence this summer in a bid to help market the technologies it has developed to rival health plans. Sandbox Industries followed with a $9 million investment late last month. Investors are generally wary of businesses that depend on government action, such as electronic medical records that were subsidized in the 2009 stimulus law. But the 2010 health overhaul law has accelerated demand for companies that use data to make health care more efficient, provide online services to help consumers shop for care and help the insurance industry adjust to new regulations. "The changes in the health system are rocket fuel for entrepreneurs," said Bob Kocher, a former Obama health policy advisor who was hired by Venrock in part to capitalize on the expertise he cultivated working on the law in the White House. Kocher is eyeing businesses that do things like help hospitals keep patients from coming back soon after treatment, a big-ticket cost for years that the health law will now tie to new penalties. Like other investors, he also anticipates that many people who gain coverage under the law will face high insurance deductibles. So, Venrock and other firms have funded Castlight Health, a technology company that helps patients choose the cheapest care. Whether such investment continues – and pays off – depends in part on Washington. Legal and political challenges to the law lie ahead in 2012 with the Supreme Court likely to weigh in and voters deciding on the next president and Congress. "If you're investing in a law with very little social support, political support and a tenuous legal basis, you're not investing – you're gambling," said David Brailer, a former Bush administration official and head of Health Evolution Partners, a private fund launched in 2007. Though Brailer is skeptical, he still expects broad change, describing his firm as "the health care version of a green investor," betting that cost pressure will fell titans of the industry as new upstarts – such as a hospice company and a radiology outsourcing group Brailer financed-- promise lower cost. Brailer and most investors interviewed for this story envision two futures: One in which the health law remains intact and providers and insurers face ever lower payments and increasing pressure to reduce costs, and another in which it is repealed and costs continue to balloon. Either way, health companies need to be rescued from out-of-control costs. "They’re all looking for life boats," Brailer said. Meanwhile, in the device sector, the combined forces of cost pressure, a stricter Food and Drug Administration and an economic recession have made it more difficult to raise capital or sell companies and that has discouraged private investment, said Rob Kuhling, a partner at Onset Ventures in Menlo Park. In response, device investors are prowling for products they can market as savers. Kuhling and others have backed companies that seek to bring a new heart valve to the United States. Medicare now pays $66,000 for open heart surgery to replace failing valves at Stanford Medical Center, in Silicon Valley. The new valve could be inserted through an artery without open surgery. Though the product itself is more expensive than typical replacement valves, it could potentially reduce hospital stays and become a lower-cost option—about $45,000 in total—for some patients, Kuhling estimated. The valve Kuhling backed is pending approval at the FDA. Another version, Edwards Lifesciences's Sapien valve, gained FDA approval Wednesday, for patients who are too ill to undergo open heart surgery. Biotechnology faces its own set of problems. The industry "is cognizant of the fact that the health system is moving towards a more cost-conscious system," said Michael Yee, an RBC Capital Markets analyst. But, he believes the market could rebound and that the industry is facing largely short-term problems. The health law introduces new fees on drug makers, for instance, but also promises millions of new customers as more people eventually gain insurance coverage. "A lot of this is near-term fear," Yee said. The same fear – of a health system with fewer resources – is, however, propelling the new wave of companies sought out by private investors. It’s hard to imagine a venture firm betting on the “largest meals-on-wheels operator” in Texas, but that’s what’s happening for Independent Living Systems. In the next couple of weeks, the company led by chief executive Nestor Plana expects to finalize a cash infusion from Oak Investment Partners. The company operates a range of long-term care management services in several states, including outsourcing for health plans that serve low-income seniors, care management, and the nutritional services Plana boasts about. Neither Plana nor Ann Lamont, an Oak venture capitalist, disclosed the amount of the investment. With the added funds, Plana will try to cash in on states' needs to rein in long-term care costs, which consume nearly half of some states' health care budgets. Meanwhile, the health law showers companies in the business of managing health for poor seniors with new business opportunities, greasing the wheels to expand managed-care to these patients and funneling money to states seeking to experiment with more efficient ways to care for them. "This is the time to get into that space, and ride that wave," said Plana, who added that this was his company’s first venture investment. He predicted the move would help turn Independent Living Systems into a national name. Younger entrepreneurs and would-be investors are starting to rethink healthcare, too. Bob Higgins, the founder of Highland Capital Partners, teaches a class on health care entrepreneurship at Harvard Business School. "My sharpest students are all trying to go to places like ZocDoc and Castlight," both venture-backed online start-ups that help patients shop for care, Higgins said. A few years ago the "classic" prospective employer for his students was an emerging biotech firm, Higgins said. But few of those companies are now hiring. - Provided by Kaiser Health News. Republish Email Facebook Digg Twitter Share [ Close ] When publishing articles from AHN we require that you follow several simple rules and that you abide by our Terms and Conditions. You may: Use and display the provided article text on a website or blog. Under the following conditions: You may not republish the article(s) wholesale, automatically or systematically; articles must be republished individually. You may not sell license or redistribute the content without specific permission. Email us if you’d like to. You must display and attribute the article in the manner specified by AHN (but not in any way that suggests that we endorse you or your use of the work). You may not remove ads, logos or tracking information from the article. You may display the article on a website, but you may not use the article for any other commercial purposes. You may not alter, rewrite, transform, or build upon the article. You may only use provided the javascript code to request the article from our systems. Copy and paste the following into your blog entry or the HTML on your page. It will automatically deliver the article as the page loads. <script type="text/javascript" src="http://www.allheadlinenews.com//syndicator?storyid=7020884860"></script> << Return to script page License THE WORK (AS DEFINED BELOW) IS PROVIDED UNDER THE TERMS OF THIS LICENSE ("LICENSE"). THE WORK IS PROTECTED BY COPYRIGHT AND/OR OTHER APPLICABLE LAW. ANY USE OF THE WORK OTHER THAN AS AUTHORIZED UNDER THIS LICENSE OR COPYRIGHT LAW IS PROHIBITED. BY EXERCISING ANY RIGHTS TO THE WORK PROVIDED HERE, YOU ACCEPT AND AGREE TO BE BOUND BY THE TERMS OF THIS LICENSE. TO THE EXTENT THIS LICENSE MAY BE CONSIDERED TO BE A CONTRACT, THE LICENSOR GRANTS YOU THE RIGHTS CONTAINED HERE IN CONSIDERATION OF YOUR ACCEPTANCE OF SUCH TERMS AND CONDITIONS. 1. Definitions "Collective Work" means a work, such as a periodical issue, anthology or encyclopedia, in which the Work in its entirety in unmodified form, along with one or more other contributions, constituting separate and independent works in themselves, are assembled into a collective whole. A work that constitutes a Collective Work will not be considered a Derivative Work (as defined below) for the purposes of this License. "Derivative Work" means a work based upon the Work or upon the Work and other pre-existing works, such as a translation, musical arrangement, dramatization, fictionalization, motion picture version, sound recording, art reproduction, abridgment, condensation, or any other form in which the Work may be recast, transformed, or adapted, except that a work that constitutes a Collective Work will not be considered a Derivative Work for the purpose of this License. For the avoidance of doubt, where the Work is a musical composition or sound recording, the synchronization of the Work in timed-relation with a moving image ("synching") will be considered a Derivative Work for the purpose of this License. "Licensor" means the individual, individuals, entity or entities that offers the Work under the terms of this License. "Original Author" means the individual, individuals, entity or entities who created the Work. "Work" means the copyrightable work of authorship offered under the terms of this License. "You" means an individual or entity exercising rights under this License who has not previously violated the terms of this License with respect to the Work, or who has received express permission from the Licensor to exercise rights under this License despite a previous violation. 2. Fair Use Rights. Nothing in this license is intended to reduce, limit, or restrict any rights arising from fair use, first sale or other limitations on the exclusive rights of the copyright owner under copyright law or other applicable laws. 3. License Grant. Subject to the terms and conditions of this License, Licensor hereby grants You a worldwide, non-exclusive, revocable (for the duration of the applicable copyright) license to exercise the rights in the Work as stated below: to reproduce the Work, to incorporate the Work into one or more Collective Works; The above rights may be exercised on freely and openly accessible web media formats . The above rights include the right to make such modifications as are technically necessary to exercise the rights in other media and formats, but otherwise you have no rights to make any alterations or Derivative Works. All rights not expressly granted by Licensor are hereby reserved, including but not limited to the rights set forth in Sections 4(d) and 4(e). 4. Restrictions.The license granted in Section 3 above is expressly made subject to and limited by the following restrictions: You may publicly display the Work only under the terms of this License, and You must include a copy of, or the Uniform Resource Identifier for, this License with every copy of the Work You publicly display. You may not offer or impose any terms on the Work that restrict the terms of this License or the ability of a recipient of the Work to exercise the rights granted to that recipient under the terms of the License. You may not sublicense the Work. You must keep intact all notices that refer to this License and to the disclaimer of warranties. When You publicly display the Work, You may not impose any technological measures on the Work that restrict the ability of a recipient of the Work from You to exercise the rights granted to that recipient under the terms of the License. This Section 4(a) applies to the Work as incorporated in a Collective Work, but this does not require the Collective Work apart from the Work itself to be made subject to the terms of this License. If You create a Collective Work, upon notice from any Licensor You must, to the extent practicable, remove from the Collective Work any credit as required by Section 4(c), as demanded. You may not exercise any of the rights granted to You in Section 3 above in any manner that is primarily intended for or directed toward commercial advantage or private monetary compensation. The exchange of the Work for other copyrighted works by means of digital file-sharing or otherwise shall not be considered to be intended for or directed toward commercial advantage or private monetary compensation, provided there is no payment of any monetary compensation in connection with the exchange of copyrighted works. If You publicly display the Work (as defined in Section 1 above) or Collective Works (as defined in Section 1 above), You must, unless a request has been made pursuant to Section 4(a), keep intact all copyright notices for the Work and provide, reasonable to the medium or means You are utilizing: (i) the name of the Original Author (or pseudonym, if applicable) if supplied, and/or (ii) if the Original Author and/or Licensor designate another party or parties (e.g. a sponsor institute, publishing entity, journal) for attribution ("Attribution Parties") in Licensor's copyright notice, terms of service or by other reasonable means, the name of such party or parties; the title of the Work if supplied; to the extent reasonably practicable, the Uniform Resource Identifier, if any, that Licensor specifies to be associated with the Work, unless such URI does not refer to the copyright notice or licensing information for the Work. The credit required by this Section 4(c) may be implemented in any reasonable manner; provided, however, that in the case of a Collective Work, at a minimum such credit will appear, if a credit for all contributing authors of the Collective Work appears, then as part of these credits and in a manner at least as prominent as the credits for the other contributing authors. For the avoidance of doubt, You may only use the credit required by this clause for the purpose of attribution in the manner set out above and, by exercising Your rights under this License, You may not implicitly or explicitly assert or imply any connection with, sponsorship or endorsement by the Original Author, Licensor and/or Attribution Parties, as appropriate, of You or Your use of the Work, without the separate, express prior written permission of the Original Author, Licensor and/or Attribution Parties. 5. Representations, Warranties and Disclaimer UNLESS OTHERWISE MUTUALLY AGREED TO BY THE PARTIES IN WRITING, LICENSOR OFFERS THE WORK AS-IS AND ONLY TO THE EXTENT OF ANY RIGHTS HELD IN THE LICENSED WORK BY THE LICENSOR. THE LICENSOR MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE WORK, EXPRESS, IMPLIED, STATUTORY OR OTHERWISE, INCLUDING, WITHOUT LIMITATION, WARRANTIES OF TITLE, MARKETABILITY, MERCHANTIBILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, OR THE ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OF ABSENCE OF ERRORS, WHETHER OR NOT DISCOVERABLE. SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OF IMPLIED WARRANTIES, SO SUCH EXCLUSION MAY NOT APPLY TO YOU. 6. Limitation on Liability. EXCEPT TO THE EXTENT REQUIRED BY APPLICABLE LAW, IN NO EVENT WILL LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY FOR ANY SPECIAL, INCIDENTAL, CONSEQUENTIAL, PUNITIVE OR EXEMPLARY DAMAGES ARISING OUT OF THIS LICENSE OR THE USE OF THE WORK, EVEN IF LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 7. Termination This License and the rights granted hereunder will terminate automatically upon any breach by You of the terms of this License. Individuals or entities who have received Collective Works (as defined in Section 1 above) from You under this License, however, will not have their licenses terminated provided such individuals or entities remain in full compliance with those licenses. Sections 1, 2, 5, 6, 7, and 8 will survive any termination of this License. Subject to the above terms and conditions, the license granted here is perpetual (for the duration of the applicable copyright in the Work). Notwithstanding the above, Licensor reserves the right to release the Work under different license terms or to stop distributing the Work at any time; provided, however that any such election will not serve to withdraw this License (or any other license that has been, or is required to be, granted under the terms of this License), and this License will continue in full force and effect unless terminated as stated above. 8. Miscellaneous Each time You distribute or publicly digitally perform the Work (as defined in Section 1 above) or a Collective Work (as defined in Section 1 above), the Licensor offers to the recipient a license to the Work on the same terms and conditions as the license granted to You under this License. If any provision of this License is invalid or unenforceable under applicable law, it shall not affect the validity or enforceability of the remainder of the terms of this License, and without further action by the parties to this agreement, such provision shall be reformed to the minimum extent necessary to make such provision valid and enforceable. No term or provision of this License shall be deemed waived and no breach consented to unless such waiver or consent shall be in writing and signed by the party to be charged with such waiver or consent. This License constitutes the entire agreement between the parties with respect to the Work licensed here. There are no understandings, agreements or representations with respect to the Work not specified here. Licensor shall not be bound by any additional provisions that may appear in any communication from You. This License may not be modified without the mutual written agreement of the Licensor and You. There are no third-party beneficiaries to this Licesnse. You waive any right to jury trial in connection with any action or litigation in any way arising out of or related to this License. You agree to pay all reasonable attorney fees and other costs incurred by Your breach of this license. This agreement will be governed and construed in accordance with the laws of the State of Florida without regard to its conflicts of law provisions. You agree to submit to the personal jurisdiction of the state and federal courts located in Palm Beach County in the State of Florida, and any cause of action which arise from use of this web site or from interpretation of these terms and conditions must be filed in the state and federal courts located in Palm Beach County, State of Florida. If any provision of this agreement shall be unlawful, void, or for any reason unenforceable, then that provision shall be deemed severable from this agreement and shall not affect the validity and enforceability of any remaining provisions. Any remaining provisions shall be given effect to the fullest extent possible. Need more news? visit FeedSyndicate for all of your content needs This is a BETA service and subject to change or cancellation. Recent Posts Most Popular Comments Recent Comments Popular Threads Advertisement Advertisement [ CLOSE ] --> [ CLOSE ] [ CLOSE ] [ CLOSE ] Submit News | Privacy Policy | Terms of Use | Contact Us | News and Content Feeds | Journalism Jobs Follow AHN on Twitter AHN Social News connects you with friends and the news © 2011 AHN All Rights Reserved | Hosted on the NewsBahn™

Other News on Sunday, 6 November 2011
Costly wreck: NASCAR parks Kyle Busch for remainder of Texas weekend
Nishikori upsets Djokovic at Swiss Indoors; Ivanovic handles Petrova at TOC
Cancer diagnosis has boxing legend Joe Frazier on ropes in fight for life
Lidstrom's three points pave way for Red Wings victory over Ducks
Orioles appear to be ready to make Dan Duquette new GM
Philly-busters: Flyers dominating Blue Jackets 8-0 after two periods
Yaya Toure's header lifts Man City over Queens Park Rangers
Quarterback Andrew Luck leads Stanford to victory over Oregon State
Red Wings turn on the firepower for 3-0 lead over Ducks
Miller powers Ohio State's potent running game to victory vs. Indiana
Dippin' Dots files for Chapter 11 bankruptcy protection
"60 Minutes" curmudgeon Andy Rooney dies at 92
James Kirkland stops Alfredo Angulo in fight-of-year candidate
LSU gains inside track to BCS title game, tops 'Bama in thrilling OT
Flyers boast eight different goal scorers, crush Bue Jackets
Red Wings break scoring slump, losing streak in blanking of Ducks
Mark Munoz gets TKO win over Chris Leben in UFC 138 main event
Ray Whitney, Boyd Gordon score as Coyotes cool off Oilers in desert
Health Warning: FDA warns consumers not to eat Bio Gaudiano brand Organic Olives Stuffed with Almonds
Devils edge Jets as Henrique nets game-winner in overtime
Greece to form new government
Health Investors' New Calculus: Save Money To Make Money
Greece at new risk of being pushed off euro
Bodies of missing Tenn. mom, Jo Ann Bain, and daughter found
Female Breasts Are Bigger Than Ever
AMD Trinity Accelerated Processing Units Now in Volume Production
The Avengers (2012 film), made the second biggest opening- and single-day gross of all-time
AMD to Start Production of piledriver
Ivy Bridge Quad-Core, Four-Thread Desktop CPUs
Islamists Protest Lady Gaga's Concert in Indonesia
Japan Successfully Broadcasts an 8K Signal Over the Air
ECB boosts loans to 1 trillion Euro to stop credit crunch
Egypt : Mohammed Morsi won with 52 percent
What do you call 100,000 Frenchmen with their hands up
AMD Launches AMD Embedded R-Series APU Platform
Fed Should not Ignore Emerging Market Crisis
Fed casts shadow over India, emerging markets
Why are Chinese tourists so rude? A few insights

USD EUR - 1 year graph		BlogMeter 1.01